Pegfilgrastim supports delivery of BEACOPP chemotherapy administered every 14 days

Journal of Supportive Oncology

Volumn 3, Issue 2 SUPPL. 1, 2005, Pages 48-49

  Engert, Andreas ^a   Doehner, Hartmut ^a   Ho, Anthony D ^a   Schmitz, Norbert ^a   Bredenfeld, Henning ^a   Hoelzer, Dieter ^a   Klimm, Beate ^a   Münz, Axel ^a   Easton, Valerie ^a   Bacon, Pamela ^a   Diehl, Volker ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADVANCED CANCER; ANEMIA; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; FEASIBILITY STUDY; FEBRILE NEUTROPENIA; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; MULTICENTER STUDY; NEUTROPENIA; OPEN STUDY; PHASE 2 CLINICAL TRIAL; PNEUMONIA; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYNCOPE; THROMBOCYTE COUNT;

EID: 20144389218     PISSN: 15446794     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (1)

1. Engert A, Deohner H, Ho AD, et al. Pegfilgtrastim supports delivery of BEACOPP chemotherapy adminstered every 14 days. Poster presented at the 46th Annual Meeting of the American Society of Hematology; December 4-7, 2004; San Diego, Calif. Abstract 1316.